Senior insider sale
Chief Scientific Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$67.1K
6.53K shares
What this filing means
HEIER JEFFREY S. plans to sell 6.53K shares of OCULAR THERAPEUTIX, INC valued at approximately $67.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001950047-26-001624
Officer· Chief Scientific Officer
Since Feb 2026
6.53K
Shares to sell
$67.1K
Approx. market value
3.06K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/22/2026
3.06KTotal acquired3.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2026 | Restricted stock vesting under a registered plan Not Applicable | 3.06K | — |
| Total | 3.06K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.47K
Market value
$41.8K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.06K
Market value
$25.3K
2/23/2026
Total
Units
6.53K
Value
$67.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/24/2025 | 3.47K | $41.8K | — | Completed |
| Planned — Approximate Date | ||||
2/23/2026 | 3.06K | $25.3K | NASDAQ | Planned |
| Total | 6.53K | $67.1K | ||